INT-1B3

N/A

Report date: 2024/02/09 20:03:39
NME

Base Information

Drug NameINT-1B3
Drug Alias NameINT-1B3
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionMicroRNA 193a replacements
TargetsMicroRNA 193a
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInterna Technologies Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInterna Technologies Bv
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A